These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 37004755)

  • 21. [The Epidemiology of Carbapenemases in Escherichia coli and Klebsiella pneumoniae Isolated in 2019 in Turkey].
    Süzük Yıldız S; Şimşek H; Bakkaloğlu Z; Numanoğlu Çevik Y; Hekimoğlu CH; Kılıç S; Alp Meşe E;
    Mikrobiyol Bul; 2021 Jan; 55(1):1-16. PubMed ID: 33590977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of In Vitro Efficacy of Ceftazidime-Avibactam, Meropenem, and Colistin Single and Binary Combinations Against Carbapenem Resistant Klebsiella pneumoniae Strains Isolated from Various Clinical Specimens].
    Köle M; Sesli Çetin E; Şirin MC; Cicioğlu Arıdoğan B
    Mikrobiyol Bul; 2022 Apr; 56(2):230-250. PubMed ID: 35477227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergence and nosocomial spread of ST11 carbapenem-resistant
    Chen CM; Guo MK; Ke SC; Lin YP; Li CR; Vy Nguyen HT; Wu LT
    J Med Microbiol; 2018 Jul; 67(7):957-964. PubMed ID: 29873627
    [No Abstract]   [Full Text] [Related]  

  • 24. Inactivation of mgrB gene regulator and resistance to colistin is becoming endemic in carbapenem-resistant Klebsiella pneumoniae in Greece: A nationwide study from 2014 to 2017.
    Hamel M; Chatzipanagiotou S; Hadjadj L; Petinaki E; Papagianni S; Charalampaki N; Tsiplakou S; Papaioannou V; Skarmoutsou N; Spiliopoulou I; Christofidou M; Papamichalopoulos N; Skalidis T; Legakis N; Fountoulis K; Perivolioti E; Kraniotaki H; Bournia M; Ioannidis A; Baron Sophie A; Rolain JM
    Int J Antimicrob Agents; 2020 Apr; 55(4):105930. PubMed ID: 32130981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality.
    Rojas LJ; Salim M; Cober E; Richter SS; Perez F; Salata RA; Kalayjian RC; Watkins RR; Marshall S; Rudin SD; Domitrovic TN; Hujer AM; Hujer KM; Doi Y; Kaye KS; Evans S; Fowler VG; Bonomo RA; van Duin D;
    Clin Infect Dis; 2017 Mar; 64(6):711-718. PubMed ID: 27940944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation, characterization, therapeutic potency, and genomic analysis of a novel bacteriophage vB_KshKPC-M against carbapenemase-producing Klebsiella pneumoniae strains (CRKP) isolated from Ventilator-associated pneumoniae (VAP) infection of COVID-19 patients.
    Mohammadi M; Saffari M; Siadat SD; Hejazi SH; Shayestehpour M; Motallebi M; Eidi M
    Ann Clin Microbiol Antimicrob; 2023 Feb; 22(1):18. PubMed ID: 36829156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surveillance of carbapenem-resistant
    Zhou Y; Zhao Z; Zeng L; Peng J; Zhou S; Min L; Ke J; Liu J
    J Med Microbiol; 2022 Jan; 71(1):. PubMed ID: 35060850
    [No Abstract]   [Full Text] [Related]  

  • 28. Molecular characterization of novel sequence type of carbapenem-resistant New Delhi metallo-β-lactamase-1-producing Klebsiella pneumoniae in the neonatal intensive care unit of an Indian hospital.
    Ahmad N; Ali SM; Khan AU
    Int J Antimicrob Agents; 2019 Apr; 53(4):525-529. PubMed ID: 30578964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High prevalence of mgrB-mediated colistin resistance among carbapenem-resistant Klebsiella pneumoniae is associated with biofilm formation, and can be overcome by colistin-EDTA combination therapy.
    Shein AMS; Wannigama DL; Higgins PG; Hurst C; Abe S; Hongsing P; Chantaravisoot N; Saethang T; Luk-In S; Liao T; Nilgate S; Rirerm U; Kueakulpattana N; Srisakul S; Aryukarn A; Laowansiri M; Hao LY; Yonpiam M; Ragupathi NKD; Techawiwattanaboon T; Ngamwongsatit N; Amarasiri M; Ounjai P; Kupwiwat R; Phattharapornjaroen P; Badavath VN; Leelahavanichkul A; Kicic A; Chatsuwan T
    Sci Rep; 2022 Jul; 12(1):12939. PubMed ID: 35902639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of imipenem/relebactam and ceftazidime/avibactam against carbapenem-resistant Klebsiella pneumoniae from blood cultures in a University hospital in Serbia.
    Zornic S; Petrovic I; Lukovic B
    Acta Microbiol Immunol Hung; 2023 Sep; 70(3):187-192. PubMed ID: 37535440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency Determination of Carbapenem-Resistant Klebsiella Pneumoniae (CRKP) Isolated from hospitals in Isfahan of Iran and Evaluation of Synergistic Effect of Colistin and Meropenem on them.
    Gheitani L; Fazeli H; Moghim S; Nasr Isfahani B
    Cell Mol Biol (Noisy-le-grand); 2018 Jan; 64(1):70-74. PubMed ID: 29412797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbapenem-resistant Klebsiella pneumoniae outbreak with monoclonal spread: Evaluation of resistance genes and ceftazidime-avibactam susceptibility.
    Arıcı N; Tanrıverdi ES; Çalık Ş; Kansak N; Adaleti R; Otlu B; Aksaray S
    Indian J Med Microbiol; 2023; 46():100431. PubMed ID: 37945124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbapenem-resistant Klebsiella pneumoniae in the Balkans: Clonal distribution and associated resistance determinants.
    Chatzidimitriou M; Kavvada A; Kavvadas D; Kyriazidi MA; Eleftheriadis K; Varlamis S; Papaliagkas V; Mitka S
    Acta Microbiol Immunol Hung; 2024 Mar; 71(1):10-24. PubMed ID: 38381174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Within-host resistance evolution of a fatal ST11 hypervirulent carbapenem-resistant Klebsiella pneumoniae.
    Pu D; Zhao J; Lu B; Zhang Y; Wu Y; Li Z; Zhuo X; Cao B
    Int J Antimicrob Agents; 2023 Apr; 61(4):106747. PubMed ID: 36758779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance of Carbapenemase Nordmann-Poirel, Modified Carbapenem Inactivation, and EDTA Carbapenem Inactivation Methods for Detecting Carbapenem-Resistant
    Sarva K; Marimuthu Ragavan R; Tadi LJ; Raja S; Narasingam A
    Microb Drug Resist; 2023 Nov; 29(11):504-509. PubMed ID: 37729073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Epidemiology and Risk Factors of Carbapenem-Resistant Klebsiella Pneumoniae Bloodstream Infections in Wuhan, China.
    Liu C; Liu L; Jin MM; Hu YB; Cai X; Wan L; Zhang HY; Li RY; Wu XJ
    Curr Med Sci; 2022 Feb; 42(1):68-76. PubMed ID: 34985611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study of genotyping and antimicrobial resistance between carbapenem-resistant
    Jian X; Li Y; Wang H; Li C; Li F; Li J; Dong J; Du T; Jiang L
    Front Cell Infect Microbiol; 2024; 14():1298202. PubMed ID: 38524181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overestimated discriminatory power of MALDI-TOF mass spectrometry for typing of carbapenem-resistant
    Jiang F; Kong Z; Cheng C; Kang H; Gu B; Ma P
    Epidemiol Infect; 2019 Dec; 147():e324. PubMed ID: 31845635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence of ST39 carbapenem-resistant Klebsiella pneumoniae producing VIM-1 and KPC-2.
    Karampatakis T; Zarras C; Pappa S; Vagdatli E; Iosifidis E; Roilides E; Papa A
    Microb Pathog; 2022 Jan; 162():105373. PubMed ID: 34954336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbapenem antibiotic stress increases bla
    Chen H; Li N; Wang F; Wang L; Liang W
    J Clin Lab Anal; 2022 Jul; 36(7):e24519. PubMed ID: 35718993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.